PharmiWeb.com - Global Pharma News & Resources
03-Oct-2023

$18.5 Billion Sleep Apnea Diagnostic System Markets - Global Size, Share, Outlook, and Opportunity Analysis, 2023-2030 with 2022 as the Base Year - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Sleep Apnea Diagnostic System Market, By Product Type, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.



Global sleep apnea diagnostic system market is projected to reach a value of $18.5 billion by 2030 from $10.7 billion in 2023, growing at a CAGR of 8.1%

The global sleep apnea diagnostic system market is gaining traction, driven by the escalating prevalence of sleep apnea and its potentially serious health consequences. Factors such as lifestyle changes and population growth have heightened the urgency for effective diagnostic methods and treatment solutions. Home sleep tests, which have seen significant advancements, now play a critical role in diagnosing sleep disorders.

A recent milestone in the market is the U.S. FDA's clearance of Sunrise's second-generation at-home sleep apnea test. This test utilizes artificial intelligence (AI) for diagnosing obstructive sleep apnea and other sleep-related breathing issues. What sets the Sunrise team apart is their innovative use of Mandibular Jaw Movements (MJM) as a bio-signal for measuring sleep quality, a method researched for decades but now incorporated into a cutting-edge device.

These advancements, along with continued R&D and regulatory approvals, indicate a burgeoning market ripe with opportunities. Whether it's the adoption of AI in diagnostic tools or the growth of home-based testing solutions, the market is clearly evolving at a fast pace, presenting numerous avenues for expansion and investment.

The report aims to provide detailed insights into these emerging market trends across various segments, pinpointing potential revenue opportunities. By understanding the market dynamics and competitive strategies employed by key players, stakeholders can make well-informed decisions that align with current trends in health technology convergence.

For organizations looking to invest or expand in this promising market, keeping an eye on advancements in AI-powered diagnostics, home sleep tests, and regulatory approvals will be crucial for shaping pro-market strategies.

Key features of the study:

  • This report provides in-depth analysis of the global sleep apnea diagnostic system market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global sleep apnea diagnostic system market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global sleep apnea diagnostic system market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sleep apnea diagnostic system market

Company Profiles

  • Koninklijke Philips N.V.
  • SOMNOmedics GmbH
  • Advanced Brain Monitoring, Inc.
  • Braebon Medical Corporation
  • Becton, Dickinson and Company
  • Itamar Medical Ltd.
  • FusionHealth
  • MGC Diagnostics Corporation
  • Natus Medical Incorporated
  • SleepMed
  • Cleveland Medical Devices Inc.
  • BMC Medical Co, Ltd.
  • ResMed Inc.

Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product Launch
  • Technological Advancements
  • PEST Analysis
  • Regulatory Scenario
  • Mergers and Acquisitions

Detailed Segmentation:

Global Sleep Apnea Diagnostic System Market, By Product Type:

  • Polysomnography (PSG) Devices
  • Ambulatory PSG Monitoring Devices
  • Clinical PSG Monitoring Devices
  • Sleep Apnea Screening Devices
  • Nasal Flow Sensors
  • Peripheral Capillary Oxygen Saturation (SPO2)
  • Actigraphy Monitoring Devices

Global Sleep Apnea Diagnostic System Market, By End User:

  • Home Care Settings
  • Hospitals
  • Sleep Centers and Clinics

Global Sleep Apnea Diagnostic System Market, By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

For more information about this report visit https://www.researchandmarkets.com/r/x0tfg4

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 03-Oct-2023